Literature DB >> 25511354

Transperineal versus transrectal prostate biopsy: our findings in a tertiary health institution.

E I Udeh1, O C Amu, I I Nnabugwu, Ofn Ozoemena.   

Abstract

CONTEXT AND
OBJECTIVE: Prostate cancer is a major public health issue. Its incidence is rising, especially in Nigeria. Prompt diagnosis is necessary by histology. Transperineal and transrectal approaches to prostate biopsy are well-documented. Both methods are fraught with complications though, most times minor. Studies carried out to compare both methods were carried out mainly on Caucasians, generating conflicting results. This study aims to compare the complication rates and tissue yield of these two methods in Nigerian men.
MATERIALS AND METHODS: Seventy-five patients completed the study. Forty-five patients had transperineal prostate biopsy (TPbx), while 30 patients had transrectal prostate biopsy. Pain perception for all patients was determined by visual analog scale; whereas the complications were ascertained by a validated purpose designed questionnaire administered on the 7 th and 30 th day post operatively.
RESULTS: The risk of rectal bleeding was higher for transrectal prostate biopsy compared to transperineal (Odds ratio: 0.03; 95% confidence interval (CI): 0.001-0.450; P = 0.012). TPbx was more painful than transrectal (P < 0.0001; df: 75; t: 4.98; 95%CI of difference in mean: -2.98-[-1.28]). There was no statistical difference between transperineal and transrectal prostate biopsy in hemospermia, fever, prostatic abscess, urethral bleeding, acute retention and tissue yield.
CONCLUSION: TPbx is more painful than transrectal prostate biopsy though with a significantly reduced risk of rectal bleeding. There appears to be no significant difference with respect to risk of fever, urethral bleeding, hematospermia, prostatic abscess and acute retention. Both routes provided sufficient prostate tissue for histology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25511354     DOI: 10.4103/1119-3077.146991

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  7 in total

1.  TRUS-guided transperineal prostate 12+X core biopsy with template for the diagnosis of prostate cancer.

Authors:  Gang Guo; Yong Xu; Xu Zhang
Journal:  Oncol Lett       Date:  2017-04-20       Impact factor: 2.967

2.  The application of a targeted periprostatic nerve block in transperineal template-guided prostate biopsies.

Authors:  Xue-Fei Ding; Yang Luan; Fei Wang; Yao-Zong Xu; Cheng-Hao Guo; Liang-Yong Zhu
Journal:  Quant Imaging Med Surg       Date:  2020-11

3.  Comparing outcomes of transperineal to transrectal prostate biopsies performed under local anaesthesia.

Authors:  Kelven Weijing Chen; Gregory Pek; Qiao Yufei; Poh Choo Toh; Nicholas Kuek; Joe King Chien Lee; Lincoln Guan Lim Tan; Woon Chau Tsang; Edmund Chiong
Journal:  BJUI Compass       Date:  2021-10-09

4.  Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis.

Authors:  Jianjian Xiang; Huaqing Yan; Jiangfeng Li; Xiao Wang; Hong Chen; Xiangyi Zheng
Journal:  World J Surg Oncol       Date:  2019-02-13       Impact factor: 2.754

5.  Awareness and knowledge about prostate cancer among male teachers in the Sunyani Municipality, Ghana.

Authors:  Bernard Yeboah-Asiamah Asare; Mercy Mawufenya Ackumey
Journal:  Afr Health Sci       Date:  2021-06       Impact factor: 0.927

6.  Effect of prostate volume on the peripheral nerve block anesthesia in the prostate biopsy: A strobe-compliant study.

Authors:  Yang Luan; Tian-Bao Huang; Xiao Gu; Guang-Chen Zhou; Sheng-Ming Lu; Hua-Zhi Tao; Bi-De Liu; Xue-Fei Ding
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

7.  Comparisons of cancer detection rate and complications between transrectal and transperineal prostate biopsy approaches - a single center preliminary study.

Authors:  Guan-Lin Huang; Chih-Hsiung Kang; Wei-Ching Lee; Po-Hui Chiang
Journal:  BMC Urol       Date:  2019-10-28       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.